110
Participants
Start Date
March 31, 2010
Primary Completion Date
March 31, 2011
Study Completion Date
July 31, 2011
florbetapir F 18
No study drug administered in this trial. Study subjects previously dosed with 18F-AV-45 in study 18F-AV-45-A07 (NCT00857415) are followed to autopsy in this extension study.
Research Site, New Hyde Park
Research Site, Albany
Research Site, Baltimore
Research Site, Durham
Research Site, Charleston
Research Site, Orlando
Research Site, Miami
Research Site, Miami Beach
Research Site, Miami Springs
Research Site, West Palm Beach
Research Site, St. Petersburg
Research Site, Fort Myers
Research Site, Sarasota
Research Site, Johnson City
Research Site, Hattiesburg
Research Site, Centerville
Research Site, St Louis
Research Site, Little Rock
Research Site, Oklahoma City
Research Site, Phoenix
Research Site, Sun City
Research Site, Irvine
Lead Sponsor
Avid Radiopharmaceuticals
INDUSTRY